
GRDN Stock Forecast & Price Target
GRDN Analyst Ratings
Bulls say
Guardian Pharmacy Service is a strong player in the growing market of long-term care pharmacy services. Its technology-enabled services, partnerships with facilities and payors, and focus on improving clinical outcomes make it well-positioned for growth. The recent strong performance in the vaccine business, expected continued growth in 2026, and efficient integration of acquisitions are all sustainable drivers for future success. Therefore, Guardian Pharmacy Service's stock has a positive outlook.
Bears say
Guardian Pharmacy Service is facing significant regulatory risks and exposure to reimbursement mechanisms, as well as potential investigational risk due to the highly regulated healthcare industry. In addition, their acquisition strategy may not be successful in turning around acquired assets and blunting the impact of negative drug price negotiations. While the company operates in a promising market with potential for consolidation, their limited trading liquidity and potential for legal issues present concerns for their financial performance and potential stock value.
This aggregate rating is based on analysts' research of Guardian Pharmacy Services Inc and is not a guaranteed prediction by Public.com or investment advice.
GRDN Analyst Forecast & Price Prediction
Start investing in GRDN
Order type
Buy in
Order amount
Est. shares
0 shares